Paradigm claims that iPPS is a 1B market for OA and that the drug is "statistically significant" and DMOAD. However, there doesn't appear to be any interest in partnering for OA...how could that be?
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.015(5.36%) |
Mkt cap ! $119.4M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.3¢ | 28.5¢ | $208.0K | 704.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 207308 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 169 | 1 |
View Market Depth
| Last trade - 14.18pm 19/09/2025 (20 minute delay) ? |
| PAR (ASX) Chart |